![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
US Rao and GA Scarborough
Department of Pharmacology, University of North Carolina, Chapel Hill 27599.
The interactions between the human P-glycoprotein (Pgp) and two different types of immunosuppressant drugs known to modulate multidrug resistance in tumor cells have been directly investigated using our newly developed drug-stimulated ATPase assay for Pgp function. The macrolides FK506 and FK520 stimulate the Pgp-ATPase activity with affinities in the 100 nM range, nearly 10 times higher than that of verapamil, a well known Pgp substrate. On the other hand, the cyclic peptides cyclosporin A and dihydrocyclosporin C do not stimulate the Pgp-ATPase activity at all. They do, however, act as potent competitive inhibitors of verapamil-stimulated Pgp-ATPase activity, with affinity constants in the 20-25 nM range. Thus, although these two classes of immunosuppressant drugs affect the Pgp in different ways, they both probably interact with high affinity at the transported drug binding site(s) of the Pgp, which would explain their ability to resensitize multidrug-resistant cells to the killing action of certain antitumor drugs. Possible implications of these findings for Pgp function, cancer chemotherapy, and immunosuppression are discussed.
This article has been cited by other articles:
|
|
 |
|
  N. Lloberas, J. Torras, G. Alperovich, J. M. Cruzado, P. Gimenez-Bonafe, I. Herrero-Fresneda, M.{m. d.}l. Franquesa, I. Rama, and J. M. Grinyo Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3111 - 3119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Cowen and W. J. Steinbach Stress, Drugs, and Evolution: the Role of Cellular Signaling in Fungal Drug Resistance Eukaryot. Cell, May 1, 2008; 7(5): 747 - 764. [Full Text] [PDF]
|
|
|
|
 |
|
 F. Shen, S. Chu, A. K. Bence, B. Bailey, X. Xue, P. A. Erickson, M. H. Montrose, W. T. Beck, and L. C. Erickson Quantitation of Doxorubicin Uptake, Efflux, and Modulation of Multidrug Resistance (MDR) in MDR Human Cancer Cells J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 95 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. F. K. Ejendal and C. A. Hrycyna Differential Sensitivities of the Human ATP-Binding Cassette Transporters ABCG2 and P-Glycoprotein to Cyclosporin A Mol. Pharmacol., March 1, 2005; 67(3): 902 - 911. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Zhou, E. Chan, S.-Q. Pan, M. Huang, and E. J. D. Lee Pharmacokinetic Interactions of Drugs with St John's Wort J Psychopharmacol, June 1, 2004; 18(2): 262 - 276. [Abstract] [PDF]
|
|
|
|
 |
|
 T. D. Bjornsson, J. T. Callaghan, H. J. Einolf, V. Fischer, L. Gan, S. Grimm, J. Kao, S. P. King, G. Miwa, L. Ni, et al. THE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVE Drug Metab. Dispos., July 1, 2003; 31(7): 815 - 832. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Gauthier, S. Weber, A.-M. Alarco, O. Alqawi, R. Daoud, E. Georges, and M. Raymond Functional Similarities and Differences between Candida albicans Cdr1p and Cdr2p Transporters Antimicrob. Agents Chemother., May 1, 2003; 47(5): 1543 - 1554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. D. Bjornsson, J. T. Callaghan, H. J. Einolf, V. Fischer, L. Gan, S. Grimm, J. Kao, S. P. King, G. Miwa, L. Ni, et al. The Conduct of In Vitro and In Vivo Drug-Drug Interaction Studies: A PhRMA Perspective J. Clin. Pharmacol., May 1, 2003; 43(5): 443 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Garrigues, N. Loiseau, M. Delaforge, J. Ferte, M. Garrigos, F. Andre, and S. Orlowski Characterization of Two Pharmacophores on the Multidrug Transporter P-Glycoprotein Mol. Pharmacol., December 1, 2002; 62(6): 1288 - 1298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Egner, F. E. Rosenthal, A. Kralli, D. Sanglard, and K. Kuchler Genetic Separation of FK506 Susceptibility and Drug Transport in the Yeast Pdr5 ATP-binding Cassette Multidrug Resistance Transporter Mol. Biol. Cell, February 1, 1998; 9(2): 523 - 543. [Abstract] [Full Text]
|
|
|
|
|
|
J. K. Horton, K. N. Thimmaiah, G. A. Altenberg, A. F. Castro, G. S. Germain, G. K. Gowda, and P. J. Houghton Characterization of a Novel Bisacridone and Comparison with PSC 833 as a Potent and Poorly Reversible Modulator of P-Glycoprotein Mol. Pharmacol., December 1, 1997; 52(6): 948 - 957. [Abstract] [Full Text]
|
|
|
|
 |
|
 W. B. Pratt and D. O. Toft Steroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones Endocr. Rev., June 1, 1997; 18(3): 306 - 360. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. S. Hemenway and J. Heitman Immunosuppressant Target Protein FKBP12 Is Required for P-Glycoprotein Function in Yeast J. Biol. Chem., August 2, 1996; 271(31): 18527 - 18534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kralli and K. R. Yamamoto An FK506-sensitive Transporter Selectively Decreases Intracellular Levels and Potency of Steroid Hormones J. Biol. Chem., July 19, 1996; 271(29): 17152 - 17156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhang, C. W. Sachs, H.-W. Fu, R. L. Fine, and P. J. Casey Characterization of Prenylcysteines That Interact with P-glycoprotein and Inhibit Drug Transport in Tumor Cells J. Biol. Chem., September 29, 1995; 270(39): 22859 - 22865. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. S. Rao and U. S. Rao Mutation of Glycine 185 to Valine Alters the ATPase Function of the Human P-glycoprotein Expressed in Sf9 Cells J. Biol. Chem., March 24, 1995; 270(12): 6686 - 6690. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Daoud, M. Julien, P. Gros, and E. Georges Major Photoaffinity Drug Binding Sites in Multidrug Resistance Protein 1 (MRP1) Are within Transmembrane Domains 10-11 and 16-17 J. Biol. Chem., April 6, 2001; 276(15): 12324 - 12330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Kerr, Z. E. Sauna, and S. V. Ambudkar Correlation between Steady-state ATP Hydrolysis and Vanadate-induced ADP Trapping in Human P-glycoprotein. EVIDENCE FOR ADP RELEASE AS THE RATE-LIMITING STEP IN THE CATALYTIC CYCLE AND ITS MODULATION BY SUBSTRATES J. Biol. Chem., March 16, 2001; 276(12): 8657 - 8664. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
